Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1954;9:321-334

This Article
Right arrow Full Text (PDF)
Right arrow Correction (v10,px)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by COLE, D. R.
Right arrow Articles by KATZ, L. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by COLE, D. R.
Right arrow Articles by KATZ, L. N.

(Circulation. 1954;9:321.)
© 1954 American Heart Association, Inc.


The Long-Term Prognosis Following Myocardial Infarction, and Some Factors which Affect It

DAVID R. COLE M.D.1; EVELYN B. SINGIAN M.D.1; LOUIS N. KATZ M.D.1

1 From the Cardiovascular Department, Medical Research Institute, Michael Reese Hospital, Chicago, I11.

This study was undertaken to establish the long-term prognosis of the initial attack of myocardial infarction. For this purpose, 285 patients who had their initial attack between 1932 and 1942, and who survived the first two months, were followed until their demise or the end of the study (Jan. 1, 1952). Two-thirds of them were found to have lived over 5 years, two-fifths over 10 years and one-tenth over 15 years. Some of the factors which determine long-term survival were analyzed. The importance of recognizing the presence of a large group of mild cases of myocardial infarction capable of long-term survival is stressed.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. S. Coller
Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene?
Arterioscler. Thromb. Vasc. Biol., April 1, 2005; 25(4): 658 - 670.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. L. Margolis, J. E. Manson, P. Greenland, R. J. Rodabough, P. F. Bray, M. Safford, R. H. Grimm Jr, B. V. Howard, A. R. Assaf, R. Prentice, et al.
Leukocyte Count as a Predictor of Cardiovascular Events and Mortality in Postmenopausal Women: The Women's Health Initiative Observational Study
Arch Intern Med, March 14, 2005; 165(5): 500 - 508.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. R. Law, H. C. Watt, and N. J. Wald
The Underlying Risk of Death After Myocardial Infarction in the Absence of Treatment
Arch Intern Med, November 25, 2002; 162(21): 2405 - 2410.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
G.R. Royston
Long-Term Anticoagulant Treatment in Coronary Disease
Angiology, March 1, 1967; 18(3): 133 - 149.
[PDF]


Home page
Arch Intern MedHome page
W. T. FOLEY, E. McDEVITT, C. SYMONS, and I. S. WRIGHT
Further Experience with Long-Term Anticoagulant Therapy
Arch Intern Med, April 1, 1955; 95(4): 497 - 502.
[Abstract] [PDF]